BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20143765)

  • 21. Clinical Characteristics and Therapeutic Outcomes of Pediatric Blepharokeratoconjunctivitis.
    Moon J; Lee J; Kim MK; Hyon JY; Jeon HS; Oh JY
    Cornea; 2023 May; 42(5):578-583. PubMed ID: 36036680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meibomitis-related keratoconjunctivitis in childhood and adolescence.
    Suzuki T; Kinoshita S
    Am J Ophthalmol; 2007 Jul; 144(1):160-1; author reply 161. PubMed ID: 17601450
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion.
    Odio CM; Kusmiesz H; Shelton S; Nelson JD
    Pediatrics; 1985 May; 75(5):819-26. PubMed ID: 4039433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of humanlike Augmentin SR (2000/125 mg) twice daily treatment on Haemophilus influenzae experimental pneumonia in rabbits.
    Croisier D; Benoit M; Durand D; Lequeu C; Piroth L; Portier H; Chavanet P
    Scand J Infect Dis; 2007; 39(2):115-21. PubMed ID: 17366027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intense Pulsed Light Therapy with Optimal Pulse Technology as an Adjunct Therapy for Moderate to Severe Blepharitis-Associated Keratoconjunctivitis.
    Ruan F; Zang Y; Sella R; Lu H; Li S; Yang K; Jin T; Afshari NA; Pan Z; Jie Y
    J Ophthalmol; 2019; 2019():3143469. PubMed ID: 31637051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and treatment of children with ocular rosacea.
    Donaldson KE; Karp CL; Dunbar MT
    Cornea; 2007 Jan; 26(1):42-6. PubMed ID: 17198012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meibomitis-related keratoconjunctivitis: implications and clinical significance of meibomian gland inflammation.
    Suzuki T
    Cornea; 2012 Nov; 31 Suppl 1():S41-4. PubMed ID: 23038034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral erythromycin treatment for childhood blepharokeratitis.
    Meisler DM; Raizman MB; Traboulsi EI
    J AAPOS; 2000 Dec; 4(6):379-80. PubMed ID: 11124676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subconjunctival crystals in paediatric blepharokeratoconjunctivitis.
    Mehta JS; Sagoo MS; Tuft SJ
    Acta Ophthalmol Scand; 2006 Aug; 84(4):557-8. PubMed ID: 16879584
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of ocular rosacea with once-daily low-dose doxycycline.
    Sobolewska B; Doycheva D; Deuter C; Pfeffer I; Schaller M; Zierhut M
    Cornea; 2014 Mar; 33(3):257-60. PubMed ID: 24452213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children.
    Nguyen CL; Chen TS; Tran K; Smith JEH; Lewis N
    Case Rep Ophthalmol Med; 2018; 2018():2602487. PubMed ID: 29967706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition and Diagnostic Criteria for Pediatric Blepharokeratoconjunctivitis.
    Morales-Mancillas NR; Velazquez-Valenzuela F; Kinoshita S; Suzuki T; Dahlmann-Noor AH; Dart JKG; Hingorani M; Ali A; Fung S; Akova YA; Doan S; Gupta N; Hammersmith KM; Tan DTH; Paez-Garza JH; Rodriguez-Garcia A
    JAMA Ophthalmol; 2024 Jan; 142(1):39-47. PubMed ID: 38127333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A blind parallel comparative study of the efficacy and safety of rovamycin versus augmentin in the treatment of acute otitis media.
    Mgbor NC; Umeh RE
    West Afr J Med; 2002; 21(2):117-20. PubMed ID: 12403032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rise in the incidence of severe pediatric blepharokeratoconjunctivitis during the COVID-19 pandemic.
    Barbara R; Khalili S; Maguire B; Mireskandari K; Ali A
    J AAPOS; 2023 Aug; 27(4):216-219. PubMed ID: 37356472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of amoxycillin/clavulanate (Augmentin) twice daily versus three times daily in the treatment of acute otitis media in children. The Augmentin 454 Study Group.
    Damrikarnlert L; Jauregui AC; Kzadri M
    J Chemother; 2000 Feb; 12(1):79-87. PubMed ID: 10768519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Focus on the diagnosis and treatment of blepharokeratoconjunctivitis in children].
    Jie Y; Wen Y
    Zhonghua Yan Ke Za Zhi; 2022 Aug; 58(8):561-564. PubMed ID: 35959599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicomicrobiological monitoring of patients with exacerbation of chronic bronchitis treated with antibacterial drugs].
    Dvoretskiĭ LI; Dubrovskaia NV; Grudinina SA; Filimonova OIu; Iakovlev SV; Sergeeva EV; Sidorenko SV
    Ter Arkh; 2006; 78(3):25-35. PubMed ID: 17019954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Amoxycillin/potassium clavulanate (augmentin)--current importance in the treatment of infection].
    Fomina IP
    Antibiot Khimioter; 1997; 42(9):36-43. PubMed ID: 9412419
    [No Abstract]   [Full Text] [Related]  

  • 39. [The clinical efficacy of augmentin (amoxicillin/clavulanate) in treating inflammatory diseases of the urogenital organs].
    Tkachuk VN
    Antibiot Khimioter; 2000; 45(3):9-11. PubMed ID: 10768059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blepharokeratoconjunctivitis in Cockayne syndrome.
    Bhojwani R; Lloyd IC; Alam S; Ashworth J
    J Pediatr Ophthalmol Strabismus; 2009; 46(3):184-5. PubMed ID: 19496505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.